Related Experiment Video
Updated: Jun 12, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Postinfectious purpura fulminans secondary to varicella-induced protein S deficiency
Gustavo Januário1, Shiva Ramroop, Delane V Shingadia
1Pediatric Department, Hospital Pediátrico de Coimbra, Coimbra, Portugal. gjanuario@netcabo.pt
Insights
Varicella (chickenpox) can lead to severe complications like purpura fulminans. This case highlights acquired protein S deficiency as a potential cause in children.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Immunology
Background:
- Varicella (chickenpox) is a common viral illness in children, typically self-limiting.
- Severe complications, though rare, can occur, necessitating further investigation into their mechanisms.
Observation:
- A 6-year-old child developed purpura fulminans following a varicella infection.
- The child presented with a severe thrombotic disorder characterized by skin necrosis.
Findings:
- The patient was diagnosed with acquired protein S deficiency.
- This deficiency was identified as the likely underlying cause of the purpura fulminans post-varicella.
Implications:
- Understanding the link between varicella and acquired protein S deficiency is crucial for managing severe post-infectious complications.
- This case underscores the importance of considering thrombotic events and their specific deficiencies in children with severe varicella sequelae.
Abstract:
Varicella is usually a benign and self-limited disease of infancy and childhood although it has been recognized that it sometimes has severe and life-threatening complications. We report a case of postinfectious purpura fulminans with acquired protein S deficiency following varicella in a 6-year-old child and discuss the underlying mechanism of postinfectious purpura fulminans.
Related Concept Videos
Chickenpox
Endocarditis II: Clinical Features of Infective Endocarditis
Smallpox
Rocky Mountain Spotted Fever
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
